Bank of Montreal Can Acquires 19,478 Shares of Corteva, Inc. $CTVA

Key Points

• Bank of Montreal Can raised its Corteva stake by 3.0% in Q3, buying 19,478 shares to own 678,799 shares valued at about $45.9 million (roughly 0.10% of the company), and institutional investors now hold about 81.54% of CTVA.
• Insider sale: Brian Titus sold 8,311 shares on Feb. 20 at an average $76.55 (a 50.67% reduction), leaving insiders with just 0.14% ownership.
• Analyst sentiment is largely positive with a consensus "Moderate Buy" and a $82.90 target; several firms raised targets (Deutsche Bank to $90, RBC to $89) though JPMorgan downgraded the rating to neutral while lifting its target to $77.

Bank of Montreal Can increased its holdings in Corteva, Inc. (NYSE:CTVA - Free Report) by 3.0% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 678,799 shares of the company's stock after purchasing an additional 19,478 shares during the period. Bank of Montreal Can owned approximately 0.10% of Corteva worth $45,907,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of CTVA. Empirical Finance LLC boosted its stake in shares of Corteva by 0.6% during the 2nd quarter. Empirical Finance LLC now owns 24,935 shares of the company's stock worth $1,858,000 after acquiring an additional 153 shares in the last quarter. Fox Run Management L.L.C. raised its stake in shares of Corteva by 5.1% in the 3rd quarter. Fox Run Management L.L.C. now owns 3,361 shares of the company's stock valued at $227,000 after acquiring an additional 164 shares in the last quarter. IFG Advisory LLC lifted its holdings in Corteva by 1.7% in the 3rd quarter. IFG Advisory LLC now owns 9,764 shares of the company's stock worth $660,000 after purchasing an additional 166 shares during the last quarter. United Community Bank lifted its holdings in Corteva by 10.5% in the 3rd quarter. United Community Bank now owns 1,849 shares of the company's stock worth $125,000 after purchasing an additional 176 shares during the last quarter. Finally, Binnacle Investments Inc boosted its position in Corteva by 54.7% during the second quarter. Binnacle Investments Inc now owns 512 shares of the company's stock worth $38,000 after purchasing an additional 181 shares during the period. 81.54% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Corteva

In related news, insider Brian Titus sold 8,311 shares of the business's stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the transaction, the insider directly owned 8,090 shares in the company, valued at $619,289.50. The trade was a 50.67% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 0.14% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on CTVA. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Corteva from $85.00 to $90.00 and gave the company a "buy" rating in a research report on Thursday, February 5th. BNP Paribas Exane raised their target price on shares of Corteva from $72.00 to $74.00 in a research note on Monday. Weiss Ratings reiterated a "hold (c-)" rating on shares of Corteva in a report on Monday, December 29th. Royal Bank Of Canada boosted their target price on shares of Corteva from $80.00 to $89.00 and gave the stock an "outperform" rating in a research report on Thursday, February 5th. Finally, JPMorgan Chase & Co. cut shares of Corteva from an "overweight" rating to a "neutral" rating and upped their price target for the company from $75.00 to $77.00 in a report on Thursday, February 5th. One analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $82.90.

Corteva Stock Up 1.4%

CTVA opened at $79.76 on Friday. The business has a 50 day moving average of $73.88 and a 200-day moving average of $69.20. The stock has a market capitalization of $53.64 billion, a price-to-earnings ratio of 50.48, a P/E/G ratio of 2.69 and a beta of 0.72. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 1-year low of $53.40 and a 1-year high of $80.90.

Corteva (NYSE:CTVA - Get Free Report) last announced its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The business had revenue of $3.91 billion for the quarter, compared to analyst estimates of $4.23 billion. During the same quarter in the previous year, the firm posted $0.32 earnings per share. Corteva's revenue was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, sell-side analysts anticipate that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be given a dividend of $0.18 per share. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva's dividend payout ratio is currently 45.57%.

Corteva Profile

Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.